- Retrophin Inc (NASDAQ: RTRX) surged 41.2 percent to $23.05. The volume of Retrophin shares traded was 3331 percent higher than normal. Retrophin disclosed that its Phase 2 DUET study of sparsentan achieved primary efficacy endpoint.
- Francesca's Holdings Corp (NASDAQ: FRAN) shares moved up 3.7 percent to $14.51. The volume of Francesca's traded was 967 percent higher than normal. Francesca's reported better-than-expected Q2 results and lifted its FY16 guidance.
- Agios Pharmaceuticals Inc (NASDAQ: AGIO) shares rose 20.4 percent to $44.92. The volume of Agios Pharmaceuticals shares traded was 956 percent higher than normal. Agios disclosed that its partner Celgene Corporation (NASDAQ: CELG) will submit a new drug application to the FDA for enasidenib based on ongoing Phase 1/2 study.
- Applied Optoelectronics Inc (NASDAQ: AAOI) shares rose 17.3 percent to $20.42. The volume of Applied Optoelectronics shares traded was 667 percent higher than normal. Applied Optoelectronics lifted its Q3 forecast.
Market News and Data brought to you by Benzinga APIs
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
